Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial

STZ/5-FU and everolimus were not statistically different in PFS rates, but STZ/5-FU achieved higher response rates.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2025-12-01
DOI
https://doi.org/10.1016/j.esmoop.2025.105922
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial

François‐Xavier Caroli‐Bosc, Aldo Scarpa, Annamaria Colao, Naureen Starling et al.
ESMO Open
Neuroendocrine Tumor Research Advances
article

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial

François‐Xavier Caroli‐Bosc, Aldo Scarpa, Annamaria Colao, Naureen Starling, L. Vestermark, Merete Krogh, Salvatore Tafuto, Elizaveta Mitkina Tabaksblat, Vicente Valentí, Anja Rinke, Isabel Sevilla, Carlo Carnaghi, Alberto Carmona‐Bayonas, J-P. Metges, Chanthirika Ragulan, Judith de Vos‐Geelen, J. Schrader, Ramón Salazar, Alexander von Werder, José Luís Zamora Manzano, Paula Jiménez‐Fonseca, Rita T. Lawlor, Rocio García‐Carbonero, Henning Jann, Ulrich Knigge, Birgit Cremer, Heinz‐Josef Klümpen, Anguraj Sadanandam, Nicholas Reed, P. Ruszniewski, Marino Venerito, Hari PS, Denis Smith, Àlex Teulé, J. Hernando, Dieter Hörsch, María Ángeles Martín, V. Navarro, Eric Baudin, Bengt O. Eriksson, Marta Benavent, J. Capdevila
article en

Abstract

STZ/5-FU and everolimus were not statistically different in PFS rates, but STZ/5-FU achieved higher response rates.

ESMO OpenVol. 10(12)
University of Verona (IT), Hebron University (PS), Royal Marsden NHS Foundation Trust (GB), Humanitas University (IT), Uppsala University Hospital (SE), Institute of Cancer Research (GB), Universität Hamburg (DE), Philipps University of Marburg (DE), Université Paris Cité (FR), Universitätsklinikum Gießen und Marburg (DE), Hôpital Beaujon (FR), Maastricht University Medical Centre (NL), Beatson West of Scotland Cancer Centre (GB), Odense University Hospital (DK), Hospital de Sant Pau (ES), Institut Gustave Roussy (FR), Aarhus University Hospital (DK), TUM Klinikum (DE), Rigshospitalet (DK), LMU Klinikum (DE), Hospital General Universitario Morales Meseguer (ES), Assistance Publique – Hôpitaux de Paris (FR), Hospital Universitario 12 De Octubre (ES), Zentralklinik Bad Berka (DE), Institut Català d'Oncologia (ES), Klinikum Magdeburg (DE), Amsterdam Neuroscience (NL), University Medical Center Hamburg-Eppendorf (DE), Hôpital Saint-André (FR), Centre Hospitalier Universitaire d'Angers (FR), Vall d'Hebron Hospital Universitari (ES), Centre Hospitalier Régional Universitaire de Brest (FR), Instituto de Biomedicina de Sevilla (ES), Hospital Universitario Central de Asturias (ES), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), Duran i Reynals Hospital (ES), Centrum für Integrierte Onkologie (DE), Amsterdam University Medical Centers (NL), Instituto de Investigación Biomédica de Málaga (ES), Charité - Universitätsmedizin Berlin (DE), University of Amsterdam (NL)
Openalex Percentile: Top 51%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.